Table 2

Comparison of demographic and treatment characteristics, BVAS, and early VDI scores in patients with WG who survived (Group A) or died (Group B). Values are mean ± SD (median).

Group AGroup Bp
Age of disease onset, yrs41.2 ± 12.3 (42.5)56 ± 9.8 (55)0.002
Time to diagnosis, mo6.9 ± 9.2 (4)4.8 ± 4.5 (3)NS
Followup time, mo53 ± 34.1 (50)12.5 ± 11.1 (9)< 0.001
Early BVAS19.9 ± 7.4 (21)21.8 ± 5.9 (21)NS
Early VDI2.6 ± 1.4 (2)4.8 ±1.8 (4.5)0.002
Corticosteroid
  Total dose17 ± 15.3 (13)7.4 ± 4.6 (6)0.002
  Total duration46.4 ± 31.3 (31)4.7 ± 5.7 (2)< 0.001
Cyclophosphamide
  Total dose43.7 ± 33.2 (42)4.3 ± 8 (2)< 0.001
  Total duration25.6 ± 21.2 (22)3.5 ± 5.1 (2)< 0.0001